ReviewCureus2026
Oncoplastic Breast Surgery: Bridging Oncological Safety and Aesthetic Excellence in the Era of Precision Surgery.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is a significant health problem worldwide, being the most frequent cancer in females and one of the most lethal. The current approach to breast cancer has moved away from the morbid Halsted radical mastectomy to breast-conserving surgery (BCS). Although BCS, supplemented by radiotherapy, has the same survival rates as the Halsted procedure, it is associated with significantly good post-operative outcomes. Oncoplastic breast surgery (OBS) combines the principles of breast cancer removal and reconstruction, allowing for the removal of larger tumors while maintaining the breast appearance by reshaping the breast tissue. In this article, the current evidence for the clinical, cosmetic, and oncological outcomes of OBS is reviewed. The evidence demonstrates the safety and potential benefits of OBS in comparison to BCS in the removal of breast cancer. The article provides a background on the various classifications of OBS, including the evolution from volume-based to ptosis-based classifications by the American Society of Breast Surgeons. A comparison is made between volume displacement techniques, such as therapeutic mammoplasties, and volume replacement techniques, including regional perforator flaps and fat grafts. The article also discusses the challenges facing the adoption of OBS across the world, including the disparity in training between surgeons in developed and developing countries. Additionally, the article presents the challenges facing the adoption of OBS, including the risk of fat necrosis and fibrosis. The article also presents the future direction in the development of OBS, including the use of extreme oncoplastic techniques in the removal of breast cancer using neoadjuvant chemotherapy. Additionally, the article presents the use of artificial intelligence in the pre-operative modeling of breast tissue using robotic-assisted tissue transfer. OBS is the current gold standard in the removal of breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.